This research is being done to determine if men with rising PSA after initial therapy for
localized prostate cancer who display the Alanine/Alanine SOD2 genotype of MnSOD and
supplement their diet with MPX have greater decrease in PSA slope following treatment
compared to men that do not supplement with MPX.
Phase:
Phase 3
Details
Lead Sponsor:
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins